Skip to content
★ Sign in to follow
YD

Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Stock: price and insider trades · China

东诚药业

CN·Mcap CN¥10.6BHealth Care

Yantai Dongcheng Pharmaceutical Group Co.,Ltd.: what insiders have been doing

We have very little insider data for Yantai Dongcheng Pharmaceutical Group Co.,Ltd. so far: the most recent filing dates from 17 May 2022. With so few records, no pattern can be drawn yet. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.

Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€12,040
1 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 15,147 of 26,897 companies
47.8
score / 100
Value
38
Quality
58
FCF yld2.1%
Earn yld1.8%
EV/EBITDA20.7x
ROE3.1%
Gross mgn51%
Net mgn7.1%
Debt/EBITDA1.4x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥12.84
Analyst consensus
2 analysts
2.00/5
CN¥13.50Target CN¥17.75(+38%)CN¥22.00
Income statement
RevenueCN¥2.7B
Gross profitCN¥1.4B51% margin
EBITDACN¥547.8M20% margin
Net incomeCN¥195.6M7.5% margin
Valuation
PER (trailing)53.5x
PER (forward)24.7x
P/Book2.4x
Beta-0.14
Balance sheet & cash
Market capCN¥10.6B
Total debtCN¥755.6M
Free Cash FlowCN¥219M
Debt / Equity25%
Profitability & ownership
ROE3.1%
ROA2.6%
% insiders42.1%
% institutions4.3%
Last declaration on 17 May 2022
Declarations1 total
  • ▼
    董事Executives
    85,692 CNY15SZSE
    7,400 shares100.0% of flowA股XSHESZSE:173000005534044860

1 of 1 declaration

About Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

Dongcheng Pharmaceutical is a company focused on the health and pharmaceutical sector, specializing in the research and development of medications. It is listed on the XSHE market.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations